This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
valuation: Archive
Is CONMED (CNMD) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CNMDNegative Net Change MCKPositive Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Should Value Investors Buy Popular (BPOP) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BPOPNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Are Investors Undervaluing PCB Bancorp (PCB) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
PCBNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Are Investors Undervaluing Century Communities (CCS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CCSNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CPRXPositive Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Is Aveanna Healthcare (AVAH) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AVAHNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Is Sharp (SHCAY) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
SHCAYNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Should Value Investors Buy First Financial Ban (FFBC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FFBCNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Is Bank First National (BFC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BFCNegative Net Change BFSTPositive Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ATATNegative Net Change LTHNegative Net Change
earnings-surprise price-change style-scores valuation
Enersys (ENS) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
EnerSys (ENS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ENSNegative Net Change VWDRYNegative Net Change
earnings-surprise price-change style-scores valuation
The Travelers Companies, Inc. (TRV) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Travelers (TRV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
TRVPositive Net Change ACGLPositive Net Change
earnings-surprise price-change style-scores valuation
Universal Health Services, Inc. (UHS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UHSNegative Net Change
earnings-surprise price-change style-scores valuation
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ANIPNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Is The Kroger Co. (KR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
KRPositive Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Should Value Investors Buy MediaAlpha (MAX) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MAXNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Are Investors Undervaluing Andritz (ADRZY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ADRZYNo Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Are Investors Undervaluing Kirin (KNBWY) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
KNBWYPositive Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Is Flex (FLEX) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FLEXNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Is CNA Financial (CNA) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CNAPositive Net Change MCYPositive Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Is Miller Industries (MLR) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MLRNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Is Fulton Financial (FULT) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
FULTNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
Should Value Investors Buy Zions Bancorporation (ZION) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ZIONNegative Net Change
cheap-stocks pe-ratio undervalued-stocks valuation value-stocks
UNIVERSAL INSURANCE HOLDINGS INC (UVE) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Universal Insurance (UVE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UVEPositive Net Change HRTGPositive Net Change
earnings-surprise price-change style-scores valuation
Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Black Diamond (BDTX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BDTXNegative Net Change EBSNegative Net Change
earnings-surprise price-change style-scores valuation